Prestige International : May 10 Consolidated Results Fiscal Year 2024 with script

About this update from Prestige International Inc.

Financial Results For The Fiscal Year Ended March 2024 April 1, 2023 ▶ March 31, 2024 May, 10 2024 Securities Code 4290 ⃰ This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail. 1 Executive Summary Medium- Term Business Plan Three Consecutive Years of Sales Growth Achieved steady growth in existing consignment businesses during the three-year period of the medium-term business plan, which was affected by the pandemic. Increased  Despite the impact of lower profitability due to the All Types of Profit completion of vaccine-related operations, all types of Year-on-Year profit increased year-on-year. Formulation of New  Theme: Connecting Growth - Origin/Next 50 Medium-Term Business Plan © 2024 PRESTIGE International Inc. All Rights Reserved. 2 2 ▍ Financial Results Summary for FY2024.3 ▍ Financial Results Summary for FY2024.3 by Segment ▍ Financial Forecast for FY2025.3 ▍ KPI: Shareholder Returns ▍ Appendix ▍ Sustainability © 2024 PRESTIGE International Inc. All Rights Reserved. 3 3 ▍ Financial Results Summary for FY2024.3 © 2024 PRESTIGE International Inc. All Rights Reserved. 4 4 Summary of Consolidated Results for FY2024.3 (million yen) Amounts are rounded down to the nearest whole unit. FY2023.3 FY2024.3 YoY Full-Year Achievement (%) Forecast Ratio Sales 54,562 58,738 +4,175 56,500 104.0% (+7.7%) Operating profit 7,840 7,921 +80 8,200 96.6% (+1.0%) Ordinary profit 8,378 8,458 +79 8,700 97.2% (+1.0%) Profit attributable to 5,318 5,791 +472 5,200 111.4% owners of parent (+8.9%) Although affected by vaccine-related operations, growth in existing businesses in major segments offset the decline of revenues. Operating profit fell short of the plan due to the impact of a temporary decline in profits from the completion of vaccine- related operations and the revision of the compensation system. However, the target for the final year of the original medium-term business plan was largely achieved. Profit attributable to owners of parent increased due to extraordinary gains from the sale of investment securities and the application of tax credits for a wage increase incentive system. © 2024 PRESTIGE International Inc. All Rights Reserved. 5 This is a summary of consolidated financial results. Regarding sales, in the Customer Business, the vaccine-related operations that we had been engaged in for the past three years were scaled down and completely terminated in H1, but the Financial Guarantee Business and the Global Business performed well, and the Automotive Business was also strong. As a result, net sales increased by about JPY4.1 billion. Regarding operating profit, although the downsizing and termination of the vaccine- related operations, which had been highly profitable, occurred as a factor that reduced sales against operating profit, the target of JPY8.2 billion was slightly higher YoY due to a slight revision of salaries outside the plan, partly due to the recent situation. Consequently, the target of JPY8.2 billion was not reached. Regarding ordinary profit, equity in earnings of affiliates was positive, and net income increased YoY due to an extraordinary gain from the sale of shares and a decrease in tax burden resulting from the taxation of higher wages. 5 Consolidated P&L Statement for FY2024.3 (million yen) Amounts are rounded down to the nearest whole unit. FY2023.3 FY2024.3 Change YoY(%) Sales 54,562 58,738 +4,175 +7.7% Cost of sales 41,263 44,981 +3,717 +9.0% Gross profit 13,299 13,757 +458 +3.4% Gross profit margin 24.4 ％ 23.4% (-1.0pt) ― SG&A 5,458 5,835 +337 +6.9% Operating profit 7,840 7,921 +80 +1.0% Operating profit margin 14.4 ％ 13.5% (-0.9pt) ― Ordinary Profit 8,378 8,458 +79 +1.0% Ordinary profit margin 15.4 ％ 14.4% (-1.0pt) ― Profit attributable to 5,318 5,791 +472 +8.9% owners of parent © 2024 PRESTIGE International Inc. All Rights Reserved. 6 Next, I will explain the income statement. As for the cost of sales, personnel expenses mainly amounted to about JPY1 billion, and purchases due to roadside assistance vendor expenses amounted to about JPY1 billion. Rent payment fees from credit card transactions amounted to about JPY260 million. In addition, depreciation and amortization increased by JPY190 million YoY. As for SG&A expenses, bad debts related to rent guarantees increased by approximately JPY130 million, and taxes and dues increased by approximately JPY38 million due to increased tax-exempt sales related to guarantees, resulting in an overall increase. 6 Consolidated Balance Sheet As of End of March, 2024 (million yen) Amounts are rounded down to the nearest whole unit. End of March End of March Change Change(%) 2023 2024 Current assets 35,892 40,740 +4,847 +13.5% Non-current assets 24,380 27,096 +2,715 +11.1% Total assets 60,273 67,836 +7,563 +12.5% Current liabilities 15,701 17,778 +2,077 +13.2% Non-current liabilities 2,753 2,832 +79 +2.9% Total liabilities 18,455 20,611 +2,156 +11.7% Shareholders' equity 36,781 40,603 +3,821 +10.4% Accumulated other 2,297 3,418 +1,120 +48.8% comprehensive income Non-controlling 2,738 3,203 +464 +17.0% interests, etc. Total net worth 41,817 47,224 +5,406 +12.9% Total liabilities and 60,273 67,836 +7,563 +12.5% equity © 2024 PRESTIGE International Inc. All Rights Reserved. 7 Next, as for the balance sheet, current assets rose due to increased advances paid, accounts receivable, and bad debts. In terms of fixed assets, there was an increase due to the construction of the BPO center in Ichinoseki, Iwate Prefecture, which will be opened in June. Liabilities increased due to unearned income related to rent guarantees, insurance premiums from clients, and customer deposits, such as change for coin-operated parking lots. 7 Quarterly Sales (million yen) Q1 Q2 Q3 Q4 60,000 50,000 40,000 30,000 24,619 27,328 23,385 24,225 22,223 6,936 20,000 6,281 6,133 6,010 6,570 6,920 5,716 6,462 6,010 5,782 10,000 5,838 6,449 5,422 6,050 6,816 5,254 5,926 5,007 5,536 6,654 0 FY12.3 FY13.3 FY14.3 FY15.3 FY16.3 © 2024 PRESTIGE International Inc. All Rights Reserved. 58,738 54,562 46,744 14,993 14,110 42,377 40,617 12,483 37,196 10,672 33,119 10,568 14,981 14,272 29,477 9,816 8,684 11,016 11,967 7,596 10,309 9,478 14,845 8,488 13,568 7,674 11,599 10,687 10,266 9,271 8,079 7,238 10,001 9,473 10,693 12,611 13,917 7,866 8,630 6,967 FY17.3 FY18.3 FY19.3 FY20.3 FY21.3 FY22.3 FY23.3 FY24.3 Due to rounding down fractions, some values may not equal the sum of the separate figures. 8 As for the quarterly results, the top line has steadily increased, although it has been slightly bumpy. 8 Quarterly Operating Profit (million yen) Q1 Q2 Q3 Q4 OPM(full-year) 10,000 14.6% 14.4% 15.0% 13.5% 12.6% 12.2% 12.8% 12.8% 12.6% 12.9% 12.0% 11.7% 7,840 7,921 8,000 11.2% 12.0% 9.8% 6,842 1,799 2,066 6,000 5,233 1,918 9.0% 4,959 4,687 2,201 4,230 1,997 1,374 3,768 1,179 4,000 1,860 6.0% 3,345 1,491 1,368 2,952 2,809 1,064 1,247 2,621 966 1,362 1,953 1,967 2,380 762 1,193 746 1,051 891 926 1,579 2,000 720 737 858 1,128 1,314 3.0% 782 1,023 619 468 877 877 672 790 745 1,886 1,889 605 651 1,484 933 978 1,289 1,296 540 609 661 775 899 0 504 0.0% FY12.3 FY13.3 FY14.3 FY15.3 FY16.3 FY17.3 FY18.3 FY19.3 FY20.3 FY21.3 FY22.3 FY23.3 FY24.3 Due to rounding down fractions, some values may not equal the sum of the separate figures. © 2024 PRESTIGE International Inc. All Rights Reserved. 9 Despite the increase in profit, the profit margin declined slightly due to the complete termination of the highly profitable vaccine-related operations in the previous quarter. 9 ▍ Financial Results Summary for FY2024.3 by Segment © 2024 PRESTIGE International Inc. All Rights Reserved. 10 10

View stock analysis, news, and events for Prestige International Inc.